Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -34.29% | -36.90% | -36.21% | -37.38% | -33.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.29% | -36.90% | -36.21% | -37.38% | -33.77% |
| Cost of Revenue | -22.85% | -25.43% | -20.99% | -35.92% | -33.65% |
| Gross Profit | -38.56% | -40.90% | -41.18% | -37.91% | -33.82% |
| SG&A Expenses | -33.49% | -20.03% | -36.43% | -41.17% | -28.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.32% | -21.64% | -32.28% | -39.57% | -29.86% |
| Operating Income | -334.15% | -159.06% | -293.78% | 86.47% | -115.89% |
| Income Before Tax | -469.01% | -600.55% | -268.38% | 127.00% | -95.46% |
| Income Tax Expenses | -86.06% | 2,376.16% | -188.20% | 115.83% | -60.29% |
| Earnings from Continuing Operations | -174.87% | -2,362.05% | -300.27% | 130.41% | -109.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -174.87% | -2,362.05% | -300.27% | 130.41% | -109.28% |
| EBIT | -334.15% | -159.06% | -293.78% | 86.47% | -115.89% |
| EBITDA | -198.91% | -126.46% | -111.87% | 161.95% | -81.98% |
| EPS Basic | -173.48% | -2,352.05% | -299.32% | 130.26% | -109.25% |
| Normalized Basic EPS | -3,898.28% | -146.10% | -267.52% | 126.86% | -100.87% |
| EPS Diluted | -173.48% | -2,458.37% | -310.00% | 129.33% | -109.28% |
| Normalized Diluted EPS | -3,898.28% | -146.29% | -268.08% | 126.70% | -100.88% |
| Average Basic Shares Outstanding | 0.53% | 0.48% | 0.49% | 0.49% | 0.36% |
| Average Diluted Shares Outstanding | 0.53% | 0.07% | 0.18% | 1.12% | -0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.84% | -- | -1.00% | 1.82% | -3.94% |